The story of InQ Biosciences technology began in the labs of the University of Alabama in Huntsville where researchers studying neurological diseases were dependent on the healthy growth of highly sensitive motor neurons. Their work was limited by the lack of control and protection offered by current cell culture technology and cell imaging. To extend cell life, the researchers developed a prototype cell and tissue growth chamber that dramatically increased the timeframe of their neurological studies. The University of Alabama in Huntsville licensed this patent-pending technology to InQ Biosciences for commercialization and introduction in the $5 billion cell culture market.
InQ Biosciences' cell culture technology automates virtually the entire cell growth process. The system has been engineered to maintain total sample sterility through the use of disposable components that provide an environment isolated from contamination. Cell samples are enclosed in a sealed, sterile chamber that rests inside a benchtop instrument. An embedded computer controls the continuous flows of nutritive media and gasses and regulates the temperature. It manages the in vivo environment according to the researcher's schedule over an experiment period that can extend for weeks without opening the sample chamber. A built-in lab-quality microscope and cell imaging system record the sample at scheduled intervals. The computer makes the data and images available to the researcher anywhere in the world via the Internet and laptop computer or smart phone. Adjustments to the experiment can be made remotely, without requiring a trip to the lab.
The InQ Cell Research System enables the simulation of hundreds of disease states including stroke, heart attack, Alzheimer's, and ALS.